论文部分内容阅读
目的观察微创颅内血肿清除术治疗高血压脑出血的临床效果。方法选取2014年1月—2016年3月新疆医科大学附属中医医院收治的高血压脑出血患者160例,采用随机数字表法分为对照组和观察组,每组80例。对照组患者入院后接受常规治疗,观察组患者行微创颅内血肿清除术。比较两组患者治疗前和治疗14 d后血肿体积、血肿周围水肿体积、美国国立卫生研究院卒中量表(NIHSS)评分、Barthe指数(BI)评分。结果治疗前两组患者血肿体积及血肿周围水肿体积比较,差异无统计学意义(P>0.05);治疗14 d后观察组患者血肿体积及血肿周围水肿体积小于对照组(P<0.05)。治疗前两组患者NIHSS评分、BI评分比较,差异无统计学意义(P>0.05);治疗14 d后观察组患者NIHSS评分低于对照组,BI评分高于对照组(P<0.05)。结论微创颅内血肿清除术治疗高血压脑出血的临床效果确切,可有效减小颅内血肿及血肿周围水肿,有利于改善患者预后。
Objective To observe the clinical effect of minimally invasive intracranial hematoma in the treatment of hypertensive intracerebral hemorrhage. Methods 160 patients with hypertensive intracerebral hemorrhage admitted from Affiliated TCM Hospital of Xinjiang Medical University from January 2014 to March 2016 were randomly divided into control group and observation group with 80 cases in each group. Patients in the control group received routine treatment after admission, and patients in the observation group underwent minimally invasive intracranial hematoma resection. The volume of hematoma, the volume of edema around hematoma, the NIH Stroke Scale (NIHSS) and the Barthe Index (BI) were compared between the two groups before treatment and 14 days after treatment. Results There was no significant difference in hematoma volume and hematoma volume between two groups before treatment (P> 0.05). After 14 days of treatment, hematoma volume and hematoma volume in the observation group were smaller than those in the control group (P <0.05). There was no significant difference in NIHSS score and BI score between the two groups before treatment (P> 0.05). NIHSS score of observation group was lower than that of control group on 14 d after treatment, and BI score was higher than that of control group (P <0.05). Conclusion minimally invasive intracranial hematoma removal of hypertensive intracerebral hemorrhage clinical effect is exact, can effectively reduce the intracranial hematoma and hematoma around the edema, help to improve the prognosis of patients.